August 16, 2021
Nippon Boehringer Ingelheim said on August 12 that it has concluded a collaborative research pact with Japan’s National Cancer Center (NCC) for the MASTER KEY Project, a private-academia initiative to propel rare cancer R&D and genomic medicine. The MASTER KEY...read more